Literature DB >> 7693763

A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

Z Liu1, L A Diaz, J L Troy, A F Taylor, D J Emery, J A Fairley, G J Giudice.   

Abstract

Subepidermal blistering associated with the human skin diseases bullous pemphigoid and herpes gestationis has been thought to be an IgG autoantibody-mediated process; however, previous attempts to demonstrate the pathogenicity of patient autoantibodies have been unsuccessful. An immunodominant and potentially pathogenic epitope associated with these blistering diseases has recently been mapped to the extracellular domain of a human epidermal antigen, BP180. Patient autoantibodies that react with this well-defined antigenic site failed to crossreact with the murine form of this autoantigen and thus could not be assayed for pathogenicity in a conventional passive transfer mouse model. As an alternative, rabbit polyclonal antibodies were generated against a segment of the murine BP180 protein homologous with the human BP180 autoantibody-reactive site and were passively transferred into neonatal BALB/c mice. The injected animals developed a subepidermal blistering disease that closely mimicked bullous pemphigoid and herpes gestationis at the clinical, histological, and immunological levels. Autoantibodies that recognize the human BP180 ectodomain are therefore likely to play an initiatory role in the pathogenesis of bullous pemphigoid and herpes gestationis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693763      PMCID: PMC288433          DOI: 10.1172/JCI116856

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180.

Authors:  G J Giudice; D J Emery; L A Diaz
Journal:  J Invest Dermatol       Date:  1992-09       Impact factor: 8.551

2.  Purification of bullous pemphigoid IgG subclasses and their capability for complement fixation.

Authors:  M Suzuki; S Harada; H Yaoita
Journal:  Acta Derm Venereol       Date:  1992-08       Impact factor: 4.437

3.  Pemphigus.

Authors:  W F LEVER
Journal:  Medicine (Baltimore)       Date:  1953-02       Impact factor: 1.889

4.  cDNA analysis predicts a cornea-specific collagen.

Authors:  J K Marchant; T F Linsenmayer; M K Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

5.  Herpes gestationis: ultrastructural identification of the extracellular antigenic sites in diseased skin using immunogold techniques.

Authors:  S Karpati; W Stolz; M Meurer; O Braun-Falco; T Krieg
Journal:  Br J Dermatol       Date:  1991-10       Impact factor: 9.302

6.  Basement zone antibodies in bullous pemphigoid.

Authors:  R E Jordon; E H Beutner; E Witebsky; G Blumental; W L Hale; W F Lever
Journal:  JAMA       Date:  1967-05-29       Impact factor: 56.272

7.  Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5'-end of the gene and the 3'-untranslated region of the mRNA.

Authors:  K Li; K Tamai; E M Tan; J Uitto
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

8.  HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome.

Authors:  Y Nishizawa; J Uematsu; K Owaribe
Journal:  J Biochem       Date:  1993-04       Impact factor: 3.387

9.  Failure to transfer bullous pemphigoid with serum from patients.

Authors:  W M Sams; G J Gleich
Journal:  Proc Soc Exp Biol Med       Date:  1971-04

10.  Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization.

Authors:  S B Hopkinson; K S Riddelle; J C Jones
Journal:  J Invest Dermatol       Date:  1992-09       Impact factor: 8.551

View more
  118 in total

1.  A major role for neutrophils in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; X Zhou; S J Swartz; J L Troy; J A Fairley; G O Till; L A Diaz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  [Bullous autoimmune dermatoses. 2: Pathogenesis].

Authors:  M Hertl; G Schuler
Journal:  Hautarzt       Date:  2002-04       Impact factor: 0.751

3.  Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8.

Authors:  Françoise Van den Bergh; Steven L Eliason; Brian T Burmeister; George J Giudice
Journal:  Exp Dermatol       Date:  2012-08       Impact factor: 3.960

4.  Type XVII collagen (BP180) can function as a cell-matrix adhesion molecule via binding to laminin 332.

Authors:  F Van den Bergh; S L Eliason; G J Giudice
Journal:  Matrix Biol       Date:  2010-10-26       Impact factor: 11.583

5.  The association of bullous pemphigoid and ulcerative colitis.

Authors:  Lisbeth Selby; Fernando De Castro; Willem J S De Villiers
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

6.  Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid.

Authors:  R Chen; G Ning; M L Zhao; M G Fleming; L A Diaz; Z Werb; Z Liu
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

Review 7.  Autoimmune bullous dermatoses in the elderly: diagnosis and management.

Authors:  Diya F Mutasim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  The role of complement in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; S J Swartz; J A Fairley; G O Till; J L Troy; L A Diaz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII.

Authors:  Kinga Csorba; Alina Sesarman; Eva Oswald; Vasile Feldrihan; Anja Fritsch; Takashi Hashimoto; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-01-20       Impact factor: 9.261

Review 10.  Management of autoimmune skin disorders in the elderly.

Authors:  Wei Jing Loo; Nigel P Burrows
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.